αααααβααΎα8AP β’ FRA
add
Agios Pharmaceuticals Inc
21.80β¬
24 ααααΆ, 10:56:30 PM ααααβααα +2 · EUR · FRA · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
22.40β¬
α
αααααααααααα
21.80β¬ - 21.80β¬
α
ααααααα½αααααΆαα
α»αααααα
19.70β¬ - 38.80β¬
ααΎαβαα»αβααΈααααΆα
1.48Β αααΈααΆα USD
ααα ααα½αααΌαααααα
6.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 19.97Β ααΆα | 86.09% |
α
αααΆαααααα·ααααα·ααΆα | 51.61Β ααΆα | -0.17% |
α
αααΌααα»ααα | -108.04Β ααΆα | -11.93% |
ααααΆααα
αααααα»ααα | -541.09 | 39.85% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | -1.85 | -6.32% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -120.31Β ααΆα | 2.72% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 0.93% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 854.42Β ααΆα | -4.40% |
ααααααααα»α | 1.30Β αααΈααΆα | -22.00% |
ααΆαααα½ααα»αααααΌαααα»α | 104.11Β ααΆα | -14.83% |
ααΌαβααααα»α | 1.19Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 58.59Β ααΆα | β |
ααααααααααΉαααααα
| 1.10 | β |
ααα
ααααααΎαααααα | -22.66% | β |
ααα
ααααααΎααΎααα»α | -23.73% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | -108.04Β ααΆα | -11.93% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -96.21Β ααΆα | 27.75% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 90.08Β ααΆα | 283.24% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 2.56Β ααΆα | -47.19% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -3.58Β ααΆα | 97.98% |
ααα αΌαααΆα
αααααΆααααααα | -62.05Β ααΆα | 42.58% |
α’αααΈ
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
ααΆααααααΎαα‘αΎα
2008
αααααβαααααΆα
αα»ααααα·α
540
